Species-specific autoantibodies in type 1 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 2, 1999, Pages 643-648

  Hampe, C S ^a   Ortqvist E ^d   Rolandsson, O ^c   Landin Olsson, M ^b   Torn C ^b   Agren A ^c   Persson, B ^d   Schranz, D B ^a   Lernmark, A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; DIABETES MELLITUS; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SERUM;

AGING; AMINO ACID SEQUENCE; ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; DIABETES MELLITUS, TYPE 1; GLUTAMATE DECARBOXYLASE; HUMANS; INSULIN; ISOENZYMES; MICE; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PEPTIDE FRAGMENTS; PROTEIN DENATURATION; RATS; SEQUENCE ALIGNMENT; SPECIES SPECIFICITY;

EID: 0033018809     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.2.643     Document Type: Article

References (28)

1. 1. Gepts W. 1965 Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes. 14:619-633.
2. 2. Lernmark Å, Klàppel G, Stenger D, et al. 1995 Heterogeneity of human islet pathology in newly diagnosed childhood insulin-dependent diabetes mellitus. Macrophage infiltrations and expression of HLA-DQ and glutamic acid decarboxylase. Virchows Arch. 425:631-640.
3. 3. Bonifacio E, Genovese S, Braghi S, et al. 1995 Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia. 38:816-822.
4. 4. Landin-Olsson M, Karlsson A, Dahlquist G, Blom L, Lernmark Å, Sundkvist G. 1989 Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin-independent) diabetes mellitus in Sweden during one year and in matched controls. Diabetologia. 32:387-395.
5. 5. Hagopian WA, Sanjeevi CB, Kockum I, et al. 1995 Glutamate decarboxylase-, insulin-and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study or Swedish children. J Clin Invest. 95:1505-1511.
6. 6. Wilkin T, Armitage M, Casey C, et al. 1985 Value of insulin autoantibodies as serum markers for insulin-dependent diabetes mellitus. Lancet. 480-482.
7. 7. Grubin CE, Daniels T, Toivola B, et al. 1994 A novel radioligand bindíng assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia. 37:344-350.
8. 8. Verge CF, Gianani R, Kawasaki E, et al. 1996 Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/ 1A-2 autoantibodies. Diabetes. 45:926-933.
9. 9. Chaillous L, Delamaire M, Elmansour A, et al. 1994 Combined analysis of islet cell antibodies which cross-react with mouse pancreas, antibodies to the Mr64,000 islet protein, and antibodies to glutamate decarboxylase in subjects at risk for IDDM. Diabetologia. 37:491-499.
10. 10. Seissler J, Amann J, Mauch L, et al. 1993 Prevalence of autoantibodies to the 65-and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest. 92:1394-1399.
11. 11. Vandewalle CL, Falorni A, Svanholm S, et al. 1995 High diagnostic sensitivity of glutamate decarboxylase autoantibodies in IDDM with clinical onset between age 20 and 40 years. J Clin Endocrinol Metab. 80:846-851.
12. 12. Roll U, Christie MR, Standl E, Ziegler A-G. 1994 Association of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of Type 1 diabetic patients. Diabetes. 43:154-160.
13. 13. Landin-Olsson M, Palmer JP, Lernmark Å, et al. 1992 Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children. Diabetologia. 35:1068-1073.
14. 14. Daw K, Ujihara N, Powers A. 1996 Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition. J Immunol. 156:818-825.
15. 15. Ujihara N, Daw K, Gianani R, Boel E, L. Yu L, Powers AC. 1994 Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes. Diabetes. 43:968-975.
16. 16. Bu D-F, Erlander MG, Hitz BC, et al. 1992 Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci USA. 89:2115-2119.
17. 17. Erlander MG, Tillakaratne NJK, Feldblum S, Patel N, Tobin AJ. 1991 Two genes encode distinct glutamate decarboxylase. Neuron. 7:91-100.
18. 18. Lee DS, Tian J, Phan T, Kaufman DL. 1993 Cloning and sequence analysis of a murine cDNA encoding glutamate decarboxylase (GAD65). Biochim Biophys Acta. 1216:157-160.
19. 19. Kaufman DJ, Erlander MG, Clare-Salzler M, Atkinson MA, Maclaren NK, Tobin AJ. 1992 Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest. 89:283-292.
20. 20. Marner B, Lernmark Å, Ludvigsson J, et al. 1985 Islet cell antibodies in insulin-dependent (type 1) diabetic children treated with plasmapheresis. Diabetes Res. 2:231-236.
21. 21. Bonifacio E, Dawkins RL, Lernmark Å. 1987 Immunology and diabetes workshops: report of the second international workshop on the standardization of cytoplasmic islet cell antibodies. Diabetologia. 30:273.
22. 22. Schmidli RS, Colman PG, Bonifacio E, Bottazzo GF, Harrison LC. 1994 High level of concordance between assays for glutamic acid decarboxylase antibodies. The First International Glutamic Acid Decarboxylase Antibody Workshop. Diabetes. 43:1005-1009.
23. 23. Falorni A, Ackefors M, Carlberg C, et al. 1996 Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies epitopes in childhood IDDM. Diabetologia. 39:1091-1098.
24. 3H recombinant human ligands. J Immunol Methods. 186:89-99.
25. 25. Bonifacio E, Lernmark Å, Dawkins RL. 1988 Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Methods. 106:83-88.
26. 26. Hagopían WA, Míchelsen B, Karlsen AE, et al. 1993 Autoantibodíes in IDDM primarily recognize the 65,000-Mr rather than the 67,000-Mr isoform of glutamic acid decarboxylase. Diabetes. 42:631-636.
27. 27. Atkinson M, Kaufman D, Newman D, Tobin A, Maclaren N. 1993 Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulindependent diabetes. J Clin Invest. 91:350-356.
28. 28. Zweig M, Campbell G. 1993 Receiver-operating characteristics (ROC) plots: a fundamental tool in clinical medicine. Clin Chem. 39:561-577.